Zhao Y, Zhang Q, Wang M, Wu B, Zhao S, Wei X
Poult Sci. 2025; 104(3):104847.
PMID: 39874788
PMC: 11810829.
DOI: 10.1016/j.psj.2025.104847.
Wang S, Ren C, Zhang Y, Pang S, Qiao S, Wu W
Cells. 2023; 12(8).
PMID: 37190032
PMC: 10137058.
DOI: 10.3390/cells12081123.
Boccuto L, Tack J, Ianiro G, Abenavoli L, Scarpellini E
Genes (Basel). 2023; 14(4).
PMID: 37107615
PMC: 10137629.
DOI: 10.3390/genes14040857.
Lazzarin T, Tonon C, Martins D, Favero Jr E, Baumgratz T, Pereira F
J Clin Med. 2023; 12(1).
PMID: 36615059
PMC: 9820907.
DOI: 10.3390/jcm12010259.
Qian M, Xia Y, Zhang G, Yu H, Cui Y
Front Oncol. 2022; 12:1024234.
PMID: 36249037
PMC: 9556982.
DOI: 10.3389/fonc.2022.1024234.
The Role and Mechanism of microRNA-1224 in Human Cancer.
Ma M, Li J, Zhang Z, Sun J, Liu Z, Zeng Z
Front Oncol. 2022; 12:858892.
PMID: 35494023
PMC: 9046935.
DOI: 10.3389/fonc.2022.858892.
Characterization of microRNA expression profiles by deep sequencing of small RNA libraries in leukemia patients from Naxi ethnic.
Shen Z, Gu X, Mao W, Cao H, Zhang R, Zhou Y
Transl Cancer Res. 2022; 8(1):160-169.
PMID: 35116745
PMC: 8798052.
DOI: 10.21037/tcr.2019.01.18.
MiR-192/NKRF axis confers lung cancer cell chemoresistance to cisplatin via the NF-κB pathway.
Li Y, Zu L, Wu H, Zhang F, Fan Y, Pan H
Thorac Cancer. 2021; 13(3):430-441.
PMID: 34953057
PMC: 8807278.
DOI: 10.1111/1759-7714.14278.
New biomarkers in peripheral blood of patients with ovarian cancer: high expression levels of miR-16-5p, miR-17-5p, and miR-638.
Saral M, Tuncer S, Odemis D, Sukruoglu Erdogan O, Erciyas S, Saip P
Arch Gynecol Obstet. 2021; 305(1):193-201.
PMID: 34370073
DOI: 10.1007/s00404-021-06138-z.
Dissecting the Interplay Mechanism between Epigenetics and Gut Microbiota: Health Maintenance and Disease Prevention.
Wu Y, Wang C, Wan J, Yao H, Yuan C
Int J Mol Sci. 2021; 22(13).
PMID: 34203243
PMC: 8267743.
DOI: 10.3390/ijms22136933.
miR‑576‑5p promotes epithelial‑to‑mesenchymal transition in colorectal cancer by targeting the Wnt5a‑mediated Wnt/β‑catenin signaling pathway.
Luo J, Liu L, Shen J, Zhou N, Feng Y, Zhang N
Mol Med Rep. 2020; 23(2).
PMID: 33300054
PMC: 7723166.
DOI: 10.3892/mmr.2020.11733.
miRNA expression profile changes in the peripheral blood of monozygotic discordant twins for epithelial ovarian carcinoma: potential new biomarkers for early diagnosis and prognosis of ovarian carcinoma.
Tuncer S, Sukruoglu Erdogan O, Erciyas S, Saral M, Celik B, Odemis D
J Ovarian Res. 2020; 13(1):99.
PMID: 32854743
PMC: 7453540.
DOI: 10.1186/s13048-020-00706-8.
miRNA-181a-5p Enhances the Sensitivity of Cells to Cisplatin in Esophageal Adenocarcinoma by Targeting CBLB.
Yang S, Wang P, Wang S, Cong A, Zhang Q, Shen W
Cancer Manag Res. 2020; 12:4981-4990.
PMID: 32612385
PMC: 7323973.
DOI: 10.2147/CMAR.S251264.
Role of microRNAs in the Regulation of Dendritic Cell Generation and Function.
Scalavino V, Liso M, Serino G
Int J Mol Sci. 2020; 21(4).
PMID: 32075292
PMC: 7072926.
DOI: 10.3390/ijms21041319.
Role of miR-221/222 in Tumor Development and the Underlying Mechanism.
Song Q, An Q, Niu B, Lu X, Zhang N, Cao X
J Oncol. 2020; 2019:7252013.
PMID: 31929798
PMC: 6942871.
DOI: 10.1155/2019/7252013.
Alleviating the progression of acute myeloid leukemia (AML) by sulforaphane through controlling miR-155 levels.
Koolivand M, Ansari M, Piroozian F, Moein S, Malekzadeh K
Mol Biol Rep. 2018; 45(6):2491-2499.
PMID: 30350234
DOI: 10.1007/s11033-018-4416-0.
Anti-Inflammatory MicroRNAs and Their Potential for Inflammatory Diseases Treatment.
Tahamtan A, Teymoori-Rad M, Nakstad B, Salimi V
Front Immunol. 2018; 9:1377.
PMID: 29988529
PMC: 6026627.
DOI: 10.3389/fimmu.2018.01377.
Comprehensive assessment for miRNA polymorphisms in hepatocellular cancer risk: a systematic review and meta-analysis.
Wang B, Jiang L, Xu Q
Biosci Rep. 2018; 38(5).
PMID: 29976775
PMC: 6153371.
DOI: 10.1042/BSR20180712.
A comprehensive evaluation for polymorphisms in family in cancer risk and prognosis: a system review and meta-analysis.
Wang B, Jiang L, Xu Q
Biosci Rep. 2018; 38(4).
PMID: 29717029
PMC: 6066660.
DOI: 10.1042/BSR20180273.
MiR-375 and Doxorubicin Co-delivered by Liposomes for Combination Therapy of Hepatocellular Carcinoma.
Fan Y, Liao J, Lu Y, Tian D, Ye F, Zhao P
Mol Ther Nucleic Acids. 2017; 7:181-189.
PMID: 28624193
PMC: 5415965.
DOI: 10.1016/j.omtn.2017.03.010.